Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Brain training from your couch: a digital program puts cognition to the test

NCT ID NCT05912556

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 30, 2026 · Last updated Sep 16, 2026 · Updated 3 times

Summary

This trial investigates whether guided, at-home digital programs can boost cognition and alter brain structure and function. Over 800 adults aged 25 to 80 will use one of two digital programs for 12 weeks. Researchers will measure changes in thinking skills and brain scans to see if mental stimulation at home can make a difference.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
two digital programs providing mental stimulation
What this could lead to
If effective, these at-home programs could offer a convenient way to sharpen thinking skills and support brain health.
What could go wrong
This is an early-stage study, and the programs may not produce meaningful cognitive or brain changes. Results depend on participants sticking with the daily routine.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

817 people

The number who actually took part.

Started

Jul 2023

Finished

Mar 2025

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

25 to 80 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Subjects 25-80 years of age. * Ability to understand and speak English, follow written and verbal instructions (English), and give informed consent (English), as assessed by study staff. * Ability to comply with all the testing and study requirements, including the ability to independently use a video conferencing tool and the ability to independently use a computer to access the web. * Ability to independently complete a daily, online intervention and outcome assessments using a web browser compatible with the intervention and assessment software on a reliable, internet-connected laptop or desktop computer. Exclusion Criteria: * Current, controlled (requiring treatment) or uncontrolled psychiatric diagnosis, including but not limited to posttraumatic stress disorder, psychosis, bipolar illness, pervasive developmental disorder, severe obsessive compulsive disorder, severe depressive or severe anxiety disorder, conduct disorder, attention-deficit/hyperactivity disorder, or other symptomatic manifestations that in the opinion of the Investigator may confound study data/assessments. * Current, controlled (requiring treatment) or uncontrolled neurological diagnosis, including but not limited to Alzheimer's Disease, other dementias, mild cognitive impairment, Huntington's Disease, Parkinson's Disease, multiple sclerosis, stroke, epilepsy, aphasia, or other condition that in the opinion of the Investigator may confound study data/assessments. * Any other medical condition in the last 90 days that in the opinion of the Investigator may confound study data/assessments. * Has been under the care of a caretaker or has not been living independently in the last 90 days. * In the last three years has used any of the following for more than two weeks continuously: Online courses, Online brain training programs * Known sensitivity (such as headaches, dizziness, nausea) to bright, stimulating video displays. * History of seizures (excluding febrile seizures), or significant motor or vocal tics, including but not limited to Tourette's Disorder and photo-sensitive epilepsy. * Visual acuity that cannot be corrected that prevents or negatively impacts computer activity. * Has participated in a clinical trial within 90 days prior to screening. * Pregnancy or planning to become pregnant. Additional Exclusion Criteria for Cohort B only: * Unwillingness or inability to comply with imaging safety protocols. * Metal implants or exposure to shrapnel. * Left-handed or ambidextrous.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Brain function are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Lumos Labs, Inc.

    San Francisco, California, 94108, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.